PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
24. February 2025

Optimizing ACS Management: Quality Metrics, Enhanced Digitization & Patient Outcome Feedback in PMcardio’s Latest Update

We’re excited to announce a significant update to PMcardio for Organizations, bringing two new features and two key enhancements designed to improve your clinical workflows.

1. Dashboard: Quality Metrics & Insight

We’re introducing comprehensive statistical dashboards that consolidate all ACS pathway-related data into one easy-to-access platform. This feature:

  • Reduces administrative burden by centralizing all relevant patient path metrics.
  • Enables cost savings by automating data collection and reducing manual effort.
  • Improves patient care through trend analysis, identifying gaps, and optimizing workflows.
  • Enhances regulatory compliance by simplifying reporting and making data more accessible.

Available to all users but specifically designed for hospital management, patient pathway coordinators, and system administrators, this dashboard consolidates key performance indicators, such as the total number of STEMI cases, E2B Times (ECG upload-to-balloon time), and many more, into a single platform, reducing fragmentation and improving efficiency.

2. Patient Outcomes Feedback Loop 

We’re closing the loop on ACS care coordination with a patient outcomes feedback feature, which enables:

  • Standardized feedback collection for hospitals to track their diagnostic accuracy and effectiveness.
  • Objective outcome gathering to assess real-world performance.
  • Enhanced learning for healthcare professionals, ensuring they receive insights on past cases.

3. Digitization v3.1 Upgrade

We are upgrading our Digitization model to version 3.1, bringing improved accuracy and better performance based on extensive testing. This update ensures:

  • More precise lead detection, with improved robustness against noise, such as horizontal lines and paper edges.
  • Higher accuracy in ECG digitization, ensuring better column separation and reducing errors for more reliable diagnostics.
  • Enhanced detection of low-quality images, minimizing the risk of misinterpretation due to poor image quality.

4. Lightning-Speed Explainability

Our AI Explainability feature is now significantly faster, enhancing efficiency in ECG report generation. Understanding the importance of rapid insights, we have optimized the process, making it five times faster – ensuring a seamless experience without unnecessary delays.

Experience the New PMcardio Today

These enhancements make PMcardio an even more powerful tool for cardiovascular care. Update your PMcardio App on your phone today and start leveraging these features straight away!

Optimizing ACS Management: Quality Metrics, Enhanced Digitization & Patient Outcome Feedback in PMcardio’s Latest Update

Optimize STEMI patient pathway with certified AI

The impact of PMcardio at the Cardiovascular Centre Aalst, Belgium:

Optimizing ACS Management: Quality Metrics, Enhanced Digitization & Patient Outcome Feedback in PMcardio’s Latest Update
Optimizing ACS Management: Quality Metrics, Enhanced Digitization & Patient Outcome Feedback in PMcardio’s Latest Update

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Powerful Medical Receives FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model

Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention.
ACC_2025

Powerful Medical at ACC 2025: Advancing AI in Cardiovascular Care

We are excited to announce that Powerful Medical will be attending the American College of Cardiology (ACC) 2025 Conference, taking place from March 29th – 31st, 2025, in Chicago, IL, USA. Once again, we have a strong presence at the conference, with multiple papers being presented, underscoring our continued leadership in AI-driven cardiovascular diagnostics.

Join 25,000 healthcare professionals who are already taking advantage of AI